Table of Contents
VAUGHAN, Ontario — Bausch + Lomb Corp. announced an affiliate has purchased the Blink product line of eye and contact lens drops from Johnson & Johnson Vision. The strategic acquisition is the latest example of the company’s commitment to increasing over-the-counter (O-T-C) consumer convenience in eye care.
“There’s a growing need for relieving the symptoms of dry eyes and dry contact lenses, and O-T-C products are often the first option consumers choose,” said John Ferris, executive vice president, Consumer, Bausch + Lomb. “The addition of Blink expands our robust portfolio of O-T-C eye care brands, enabling us to provide more choices for consumers and eye care professionals.”
According to a 2022 Gallup Study, 57% of American adults report suffering from eye dryness, and of them, nearly half (48%) use O-T-C lubricant drops to obtain relief. The incidence is increasing, with a strong correlation between the amount of time spent on digital devices and reported dry eyes.1 In addition, contact lens discomfort and contact lens dryness impacts a third of the 45 million contact lens wearers in the United States.
The Blink portfolio of eye drops consists of a variety of eye drops and contact lens rewetting drops that provide immediate and long-lasting symptom relief. The products that are part of the acquisition include the following:
- Blink Tears Lubricating Eye Drops;
- Blink Tears Preservative Free Lubricating Eye Drops;
- Blink GelTears Lubricating Eye Drops;
- Blink Triple Care Lubricating Eye Drops;
- Blink Contacts Lubricating Eye Drops; and
- Blink-N-Clean Lens Drops.
More information about Blink eye drops can be found at www.justblink.com.
Under the terms of the deal, Bausch + Lomb agreed to acquire the Blink product line for $106.5 million with cash on hand.
